IBM’s AI and the key to finding a cure for Alzheimer’s

IBM is currently working on what looks to be a promising machine learning algorithm. The algorithms main purpose is to detect and help slow down the progress of Alzheimers disease. Alzheimers is a chronic neurodegenerative disease. It causes a person to lose memory at an abnormally faster rate, confusion and even affects their ability to perform simple day-to-day tasks. The disease currently has no cure, but the new machine learning algorithm is a step in the right direction and looks promising as it hopes to overcome some of the obstacles in the diagnosis of the disease in patients.

IBM Australia published details as to how the AI can be used to predict the level of severity and help reduce the progression rate of the disease.

International Business Machines Corporation (IBM) is an American multinational information technology company

International Business Machines Corporation (IBM) is an American multinational information technology company

A researcher at IBM, from the genomics team wrote:

“At IBM Research, our mission is to use AI and technology to understand how to help clinicians better detect and ultimately prevent these diseases in their early stages. 

Whether that’s through retinal imaging, blood biomarkers or minor changes in speech, we envision a future in which health professionals have a wide array of easily accessible data available to more clearly identify and track the onset and acceleration of these conditions.”

The technology certainly looks very promising as IBM has claimed that the AI’s ability to predict the risk of Alzheimer’s was 77%.